Browse the evidence

Type 2 diabetes mellitus is associated with a significantly higher prevalence of sarcopenia (defined by low lean mass and muscle weakness) compared to healthy controls, independent of diabetes duration or glycemic control.

If you have Type 2 Diabetes, you are at significantly higher risk for muscle loss than someone without diabetes, even if your blood sugar is well-controlled. This loss is not just 'aging'; it is a specific complication of the disease. You should ask your doctor to check your muscle strength (e.g., handgrip) and lean mass, as early detection allows for rehabilitation to restore physical capacity.

Higher Body Mass Index (BMI) and the presence of osteoporosis increase the likelihood of sarcopenia in Type 2 Diabetes patients, while hypertension and a healthy diet decrease it.

For diabetics, maintaining a healthy diet (specifically high fruit and vegetable intake) is a powerful protective factor against muscle loss, potentially more so than just managing blood sugar. Conversely, having osteoporosis significantly increases your risk of sarcopenia. Managing blood pressure and maintaining a healthy weight are also critical components of preserving muscle mass.

Exercise-induced amenorrhea in female runners is associated with significant reductions in cortical and trabecular bone density and mineral content compared to eumenorrheic runners and normal controls.

If you are a female runner who has stopped menstruating for more than 6 months, your bone density may be decreasing despite your high activity levels. This is likely due to low estrogen. You should consult a physician to address the amenorrhea, as exercise alone may not protect your bones in this state.

In nonobese adolescents and young women with PCOS, treatment with flutamide (62.5 mg/d) and metformin (850 mg/d) reverses hyperinsulinemic hyperandrogenism, reduces abdominal fat mass, and increases lean body mass.

For nonobese women with PCOS, combining low-dose flutamide (62.5 mg) and metformin (850 mg) daily at dinner for 9 months can significantly improve body composition by reducing abdominal fat and increasing lean mass, without necessarily changing total body weight. This approach addresses the underlying hormonal and metabolic drivers of PCOS more effectively than oral contraceptive monotherapy.

In nonobese women with PCOS, combining ethinylestradiol-drospirenone with flutamide-metformin reverts adipocytokine balance and body composition toward normal, improving long-term cardiovascular perspectives.

For women with PCOS who are at risk of pregnancy, combining a standard oral contraceptive (ethinylestradiol-drospirenone) with low-dose flutamide (62.5 mg) and metformin (850 mg) daily for 9 months can significantly improve body composition and metabolic markers. This approach offers the benefits of pregnancy protection along with the metabolic advantages of insulin sensitization and androgen blockade.

Long-term pharmacotherapy for obesity is consistent with the consensus that obesity is a chronic disease requiring long-term management, as short-term interventions fail to sustain weight loss.

Treat obesity as a chronic condition, not a short-term goal. Just like managing blood pressure, it requires ongoing management. This mindset shift is crucial for deciding whether to use long-term pharmacotherapy.

Abdominal obesity is a key risk factor for GERD symptoms and complications, independent of overall BMI in some contexts.

Focus on reducing belly fat, not just total weight. Abdominal obesity puts direct pressure on your stomach, worsening reflux. Measures like waist circumference are important indicators of risk.

Anti-obesity drugs (phentermine/topiramate, liraglutide, naltrexone/bupropion, lorcaserin, orlistat) produce clinically significant weight loss (2.9% to 6.8% placebo-subtracted) over 12+ months, but require careful risk-benefit assessment due to adverse effects and high cost.

If lifestyle changes aren't enough, anti-obesity drugs can help you lose 3-7% more weight than placebo over a year. However, these drugs have side effects and costs. You must discuss your specific health history with a doctor to choose the right option, as some drugs have been withdrawn due to safety concerns like cancer risk.

Liraglutide (3.0 mg) produces significant weight loss (-5.4% placebo-subtracted) and improves cardiovascular risk factors, but has a high discontinuation rate due to gastrointestinal side effects.

Liraglutide is a daily injection that helps lose about 5% more weight than placebo and improves heart health markers. However, it often causes nausea and vomiting, leading many patients to stop taking it.

High-calcium diets (≥1.2%) reduce adipocyte intracellular calcium, thereby suppressing lipogenesis and stimulating lipolysis, which accelerates fat loss during caloric restriction.

To maximize fat loss, ensure your diet provides about 1000mg of calcium daily, preferably from dairy sources like yogurt or milk, while maintaining a caloric deficit. This approach accelerates fat loss and specifically targets abdominal fat.

Maintaining a BMI between 25 and 30 kg/m2 is responsible for the majority of the population attributable risk for coronary heart disease mortality.

Keeping your BMI below 30, and ideally below 25, significantly reduces your risk of dying from heart disease. This benefit applies even if you are not clinically obese (BMI > 30).

Adaptive thermogenesis (AT) during weight loss is a real but modest phenomenon, averaging approximately 120 kcal/day (0.5 MJ), with a prevalence of 29-50% depending on the weight loss strategy, and is largely independent of the magnitude or rate of weight loss.

When you lose weight, your body does reduce its energy expenditure slightly (adaptive thermogenesis), averaging about 120 calories per day. This is a real physiological response, but it is modest and does not prevent further weight loss if you maintain your caloric deficit. Do not expect your metabolism to 'break' or stop your progress; consistency in your energy intake relative to your new body size is what matters.

For very short bouts of physical activity (less than 1 minute), a minimum proportion of vigorous intensity (at least 12-15%) is required to significantly reduce the risk of Major Adverse Cardiovascular Events (MACE), though all-cause mortality benefits may appear at lower vigorous thresholds.

If you can only manage very short bursts of activity (under a minute), make sure they include some vigorous effort, like running up stairs quickly or walking very fast. This high-intensity component is crucial for protecting your heart when the duration is minimal.

A proprietary supplement containing 400 mg riboflavin, 600 mg magnesium, and 150 mg coenzyme Q10 taken daily for 3 months significantly reduces migraine pain intensity and disease burden compared to placebo, though it may not significantly reduce the total number of migraine days in underpowered trials.

If you suffer from frequent migraines and want to avoid prescription preventatives, try a supplement containing 400mg riboflavin, 600mg magnesium, and 150mg CoQ10 daily for at least 3 months. Expect a reduction in pain severity and overall disease burden, even if the number of migraine days doesn't drop drastically. Be aware that your urine may turn bright yellow (harmless) and you might experience mild digestive issues due to the magnesium.

Obesity-related sub-acute chronic inflammation acts as a pathologic mediator for both type 2 diabetes and atherosclerotic cardiovascular disease, with inflammatory markers like CRP predicting risk independently of weight.

If you have obesity or type 2 diabetes, your body's chronic low-grade inflammation is likely driving your risk for heart disease and worsening insulin resistance. While weight loss reduces this inflammation, specific anti-inflammatory strategies (like certain diabetes or cardiovascular drugs) may offer additional protection. Discuss with your doctor whether your current regimen addresses inflammatory risk, not just blood sugar or weight.

Acute vigorous submaximal exercise (67% VO2max for 60 minutes) significantly increases circulating GDF15 levels in humans, with levels continuing to rise during the recovery period.

Performing vigorous exercise (around 67% of your max capacity) for an hour triggers a significant rise in GDF15, a hormone linked to appetite suppression and energy balance. This rise continues for at least two hours after you stop exercising. While this doesn't mean your muscles are releasing the hormone directly, the systemic effect is real and substantial.

The metabolic effects of dietary fiber on host phenotypes (adiposity, liver triglycerides, serum glucose) are modulated by the composition of the gut microbiome, meaning identical fiber interventions produce divergent health outcomes depending on the individual's microbial community.

Don't assume all fiber supplements or high-fiber diets will yield the same results for you as they do for others. Your gut bacteria determine how fiber affects your metabolism. If you aren't seeing metabolic improvements from a specific fiber type, it may be due to your unique microbiome composition rather than the fiber itself being ineffective for everyone.

Isocaloric substitution of fructose for other carbohydrates significantly decreases diastolic and mean arterial blood pressure.

Substituting fructose for other carbohydrates at the same calorie level may slightly lower diastolic and mean arterial blood pressure.

Chronic insufficient sleep (<6 hours/night) and circadian misalignment in military personnel cause significant mental and physical derangements, including increased risk for cardiovascular disease, PTSD, and cognitive failure.

Prioritize 7-9 hours of sleep as a non-negotiable part of your daily routine, especially before high-stress operations. Treat sleep with the same discipline as physical training. If you are struggling with sleep, address it early to prevent long-term health issues like cardiovascular disease or PTSD.

Night shift work and rapid time-zone changes disrupt circadian rhythms, leading to increased morbidity, mortality, and cognitive impairment.

If you work night shifts, use bright light exposure during your shift and wear blue-light-blocking glasses on your commute home. Prioritize a dark, quiet sleeping environment during the day. Be aware that long-term night work increases health risks, so monitor your health closely.

An acute bout of either endurance or resistance exercise significantly increases circulating levels of anabolic hormones (testosterone, estradiol, growth hormone) in females aged 19-69, regardless of chronological age.

If you are a woman between 19 and 69, doing a standard workout (either cardio or weights) will trigger a temporary spike in key anabolic hormones like testosterone and growth hormone. This happens regardless of your age, provided you are reasonably active. You don't need to be an elite athlete to get this hormonal response; typical recreational exercise intensities are sufficient.

Resistance exercise specifically increases Dehydroepiandrosterone (DHEA) levels, whereas endurance exercise does not significantly change DHEA in females.

If you are looking to boost DHEA specifically, resistance training (weights) appears to be the more effective modality compared to steady-state cardio. Endurance exercise did not significantly change DHEA levels in this study.

Daily consumption of 10g flaxseed mucilage for 6 weeks improves insulin sensitivity in obese postmenopausal women, evidenced by reduced serum C-peptide and insulin release during an oral glucose tolerance test and an increased Matsuda index.

If you are an obese postmenopausal woman, adding 10 grams of flaxseed mucilage to your daily diet (e.g., in breakfast buns) for 6 weeks can significantly improve your insulin sensitivity. This benefit occurs independently of increasing the abundance of common 'good' gut bacteria like Faecalibacterium, suggesting the mechanism may involve other metabolic pathways or short-chain fatty acid production not captured by simple bacterial counts.

Elevated circulating levels of branched-chain amino acids (BCAAs: valine, leucine, isoleucine) are positively associated with insulin resistance (IR) and predict a higher risk of developing type 2 diabetes.

High blood levels of BCAAs are a strong warning sign for developing type 2 diabetes, especially in overweight individuals. This is likely due to your body's reduced ability to process these amino acids (impaired catabolism) rather than just eating too much protein. Focus on improving metabolic health through weight management and exercise to enhance your body's ability to clear BCAAs, rather than fearing dietary protein.